Equibles does not estimate personal net worth.
Get an email with a short summary when Scholar Rock Holding Corp publishes a filing, an earnings call transcript or a press release.
Get SRRK alertsVikas Sinha is recorded as CFO at Scholar Rock Holding Corp (SRRK). The newest filing on record that lists Vikas Sinha as CFO at Scholar Rock Holding Corp (SRRK) is dated April 22, 2026. Scholar Rock Holding Corp reported in an 8-K filed April 28, 2025 that Vikas Sinha was appointed Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective April 27, 2025. Vikas Sinha has spoken on 5 earnings calls across 1 company, most recently for Scholar Rock Holding Corp on August 6, 2026. Scholar Rock Holding Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Scholar Rock Holding Corp includes David Hallal (CEO and Board Member), Dr. Jay Backstrom (CEO and Board Member), Jay Backstrom, M.D., M.P.H. (CEO and Board Member) and 7 others.
“On April 26, 2025, the Board appointed the following individuals as officers of the Company, each appointment effective as of the Transition Date:”
“As we have shared previously, our financial objectives for 2026 remain focused on supporting our commercial bill to deliver a strong epitigromab launch, funding R&D activities to advance our pipeline and expand our leadership in the myostatin and muscle space, and continuing to evaluate opportunities to strengthen our…”
“As we have shared previously, our financial objectives for 2026 remain focused on supporting our commercial build to deliver a strong apitegromab launch, funding R&D activities to advance our pipeline and expand our leadership in the myostatin and muscle space and continuing to evaluate opportunities to strengthen our…”
“Our overarching objectives are to fund our R&D activities to expand our leadership in the myostatin and muscle space, support a strong commercial launch, and extend our runway to meet our eventual timelines for apitegromab approval.”
“I'm pleased to provide our Q2 business update and provide insights into how we are thinking about resource allocation in the future.”
“I'm pleased to provide our business update and insights into how we are thinking about resource allocation in the future.”
Start not stated–present
Last confirmed April 22, 2026
Biotechnology · Healthcare
CFO
